Return to Search

La chélation dans le traitement des troubles du spectre autistique (TSA)

Chelation for Autism Spectrum Disorder (ASD)

By James, Stephen; Stevenson, Shawn W.; Silove, Natalie; Williams, Katrina with Cochrane France [trans.]

Summary

This online article, written in French, summarizes a review conducted to determine whether chelation is an effective treatment for people on the autism spectrum. It concludes that there is no clinical trial evidence to suggest that chelation is effective, while reports of serious adverse effects mean that risks of chelation outweigh benefits.

This resource is available in Croatian, English, French, Spanish and Japanese.

Cochrane is a “global independent network of researchers, professionals, patients, carers, and people interested in health.” [Website] The network reviews evidence about health treatments.

For full text or more information

Visit www.cochrane.org/fr/CD010766/la-chelation-dans-le-traitement-des-troubles-du-spectre-autistique-tsa

Subject(s)

This online article is in French

Publication:

Cochrane
2015

Is there a mistake in this record?
Please email us at info@actcommunity.ca

ACT provides the resources gathered in the Autism Information Database as a service. We cannot guarantee the suitability or effectiveness of any of the resources listed. We caution all users to be critical consumers; see MedlinePlus Guide to Healthy Web Surfing. ACT reserves the right to remove or refuse a listing, at our discretion.